Sonography of the Optic Nerve Sheath Diameter for Detection of Elevated Intracranial Pressure (ICP)
NCT ID: NCT03529370
Last Updated: 2020-02-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
100 participants
OBSERVATIONAL
2017-01-01
2019-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Optic Nerve Sheath Diameter in Patients With Intracranial Pathology
NCT02361671
Non-invasive Intracranial Pressure Monitoring in Brain Tumor Patients
NCT07286396
Optic Nerve Sheath Diameters in Idiopathic Intracranial Hypertension Patients
NCT04603118
Measurement of the Optic Nerve Diameter in Different Healthcare Operators
NCT06830460
Assessment of Intracranial Pressure Using Optic Nerve Sheath Diameter in Head Trauma in Assiut University
NCT06726681
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Intractable high ICP is the most common "terminal event" leading to death in neurosurgical patients. The association between the severity of intracranial hypertension and poor outcome after severe head injury is well recognized. Outcomes tend to be good in patients with normal ICP, whereas those with elevated ICP are much more likely to have an unfavorable outcome. Elevated ICP carries a mortality rate of around 20%.
The rapid recognition of elevated ICP is therefore of obvious and paramount importance so that it can be monitored and so that therapies directed at lowering ICP can be initiated. A raised ICP is measurable both clinically and quantitatively. Continuous ICP monitoring is important both for assessing the efficacy of therapeutic measures and for evaluating the evolution of brain injury.
The goal of ICP monitoring is to ensure maintenance of optimal CPP. The ICP also forms a basis for medical or surgical intervention in cases of increased ICP with agents such as 3% sodium chloride (NaCl), mannitol, or diuretics (Loop diuretics), ventriculostomy, cerebrospinal fluid (CSF) diversion, and phentobarbital coma or surgical decompression in cases of intractable ICP elevation that do not respond to conservative management.
ICP monitoring may be discontinued when the ICP remains in the normal range within 48-72 hours of withdrawal of ICP therapy or if the patient's neurological condition improves to the point where he or she is following commands.
Since many investigators have questioned invasive ICP monitoring in improving patient outcomes, the invistigators tried to find noninvasive method of ICP monitoring.
The optic nerve sheath is contiguous with the dura mater, and its contents are contiguous with the subarachnoid space. Thus, raised intracranial pressure (ICP) leads to an increase in the optic nerve sheath diameter.
A-mode sonography was first used for visualization of the optic nerve sheath; however, it was not until 1994, when Hansen et al used B-mode sonography, when the approach to measurement was standardized. Sonographic studies of cadaveric optic nerves together with the work of Hansen et al established that the greatest degree of distension of the sheath occurred 3 mm behind the optic globe. This location has become the standard measurement point.
As a technique, ocular sonography is quickly learned; Tayal et al showed that with an experienced operator, 10 scans with 3 abnormal scans should be sufficient training, whereas in new ultrasound operators, 25 may be needed. In addition to these findings, measurement of both eyes can be performed in less than 4 minutes.
the invistigators chose CT as the reference gold standard for detection of raised ICP as simple noninvasive method in critically ill patients. Raised ICP is diagnosed with CT on a daily basis in clinical practice. Treatments are initiated, hemicraniectomies are performed, and intraventricular shunts are inserted, all on the basis of raised ICP as seen on imaging.
The findings of elevated ICP in cranial CT (CCT) include:
1. changes in ventricular sizes;
2. lessening in basilar cistern sizes;
3. narrowing or eliminating in sulci;
4. transfalcine herniation; and
5. changes in the rate of grey/white matter. So in this study the invistigators chose to measure optic nerve sheath diameter by sonography for diagnosis of elevated ICP in comparison to brain CT as the reference gold standard for detection of raised ICP
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
optic nerve ultrasound
sonograhy of the optic nerve sheath diameter
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Patients with traumatic brain injury
2. Patients with intracranial tumours
3. Patients with hepatic encephalopathy
4. Cerebral edema: Due to head injury, ischemic stroke with vasogenic edema, hypoxic or ischemic encephalopathy, postoperative edema
Exclusion Criteria
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Heart Institute, Egypt
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Islam Hassan Mohamed Elsadek Abulnaga
Specialist of critical care medicine, National heart institute, Cairo, Egypt
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mohamed H Abdallah, MD
Role: STUDY_DIRECTOR
Cairo University
Suzy F Michael, MD
Role: STUDY_DIRECTOR
Cairo University
Hassan K Nagi, MD
Role: STUDY_DIRECTOR
Cairo University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National heart institute , Imbaba
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Robba C, Cardim D, Tajsic T, Pietersen J, Bulman M, Rasulo F, Bertuetti R, Donnelly J, Xiuyun L, Czosnyka Z, Cabeleira M, Smielewski P, Matta B, Bertuccio A, Czosnyka M. Non-invasive Intracranial Pressure Assessment in Brain Injured Patients Using Ultrasound-Based Methods. Acta Neurochir Suppl. 2018;126:69-73. doi: 10.1007/978-3-319-65798-1_15.
Wang LJ, Chen LM, Chen Y, Bao LY, Zheng NN, Wang YZ, Xing YQ. Ultrasonography Assessments of Optic Nerve Sheath Diameter as a Noninvasive and Dynamic Method of Detecting Changes in Intracranial Pressure. JAMA Ophthalmol. 2018 Mar 1;136(3):250-256. doi: 10.1001/jamaophthalmol.2017.6560.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Optic nerve sonography and ICP
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.